Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

Targeting a mitochondrial STAT3 complex for lung cancer

October 12, 2023 3:48 PM UTC

Targeting STAT3-LRPPRC-SLIRP, a mitochondrial complex that promotes mitochondrial mRNA stability and translation, could help treat lung cancer by decreasing mitochondrial energy production in tumor cells  

Immunoprecipitation-mass spectrometry in a human lung cancer cell line identified the mitochondrial protein LRPPRC and the RNA-binding protein SLIRP as mitochondrial STAT3 interactors, and in tissue microarrays of early-stage resected lung cancer biopsies, STAT3, LRPPRC, and SLIRP protein expression was higher than in matched healthy tissue...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article